Physica KR: In Vivo Kinematic Analysis of a Novel Total Knee Replacement Implant

Limacorporate S.p.a1 site in 1 country23 target enrollmentJune 2015

ConditionsTotal Knee Replacement

Overview

Phase: N/A
Intervention: Not specified
Conditions: Total Knee Replacement
Sponsor: Limacorporate S.p.a
Enrollment: 23
Locations: 1
Primary Endpoint: Assessment of the roll-back mechanism by measuring the contact point between tibia and femur components in millimeters
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to assess the in vivo kinematics and range of motion of a single-surgeon clinical series of TKA performed with a fixed-bearing cruciate retaining total knee arthroplasty that has a roll-back mechanism and compare it with the kinematic of the normal healthy knee.

Patients would be evaluated by fluoroscopic examination during weight bearing activities (lounging, kneeling and stairs climbing).

Registry

clinicaltrials.gov

Start Date

June 2015

End Date

November 2018

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Limacorporate S.p.a

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patientsoperated in The Royal Bournemouth Hospital NHS Foundation Trust and who has received a Physica KR implant
•Patients achieving a ROM ≥ 100° at 6 week follow-up in the Physica KR clinical trial (K-06 Study protocol 30/10/2013 v 1.0);
•Patients affected by primary or secondary OA before surgery;
•Patients with an appropriate intial fixation and stability of the knee prosthesis;
•Patients with undamaged and functional collateral and posterior cruciate ligaments (no ligamentous imbalance or pain);
•Patients who understand the requirements of the study and are willing and able to comply with activities required for fluoroscopic examination;
•Patients who have signed the Ethics Committee approved study-specific Informed Consent Form.

Exclusion Criteria

•Patients with a ROM \< 100° at 6-week follow-up in Physica KR clinical trial (K-06- Study protocol 30/10/2013 v 1.0);
•Patients affected by rheumatoid arthritis;
•Patients with malalignment or axial malrotation of the knee prosthesis;
•Patients who had or have planned a surgery on their uninvolved knee within a year;
•Muscular insufficiency or absence of muscoligamentous supporting structures required for adequate soft tissue balance;
•Patients who have significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery and evaluation;
•Patients who have neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device;
•Any psychiatric illness that would prevent comprehension of the details and nature of the study;
•Participation in any experimental drug/device study within the 6 months prior to the preoperative visit, excluding the Physica KR clinical trial (K-06 Study protocol 30/10/2013 v 1.0);
•Female patients who are pregnant, nursing, or planning a pregnancy.

Outcomes

Primary Outcomes

Assessment of the roll-back mechanism by measuring the contact point between tibia and femur components in millimeters

Time Frame: 6 months after surgery

Using a software to replicate the movement using CAD models. The movement is studied and the distance made by the femur on the tibia is calculated giving the information of the roll back.